[go: up one dir, main page]

NO983178L - Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms - Google Patents

Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms

Info

Publication number
NO983178L
NO983178L NO983178A NO983178A NO983178L NO 983178 L NO983178 L NO 983178L NO 983178 A NO983178 A NO 983178A NO 983178 A NO983178 A NO 983178A NO 983178 L NO983178 L NO 983178L
Authority
NO
Norway
Prior art keywords
prophylaxis
preparation
treatment
pharmaceutical composition
menopausal symptoms
Prior art date
Application number
NO983178A
Other languages
Norwegian (no)
Inventor
Michael Shalmi
Niels Korsgaard
Birgitte Hjort Guldhammer
James Robertson Piggott
Virender Mohan Labroo
Steven Bain
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO983178L publication Critical patent/NO983178L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Foreliggende oppfinnelse til- veiebringer nye anvendelser av forbin- delser med den generelle formel (I) hvor R1, R* og R5 uavhengig av hverandre er hydrogen, hydroksy, halogen, tri- fluormetyl, Cj.6-alkyl, C^-alkoksy eller (tertiært aminoHC^-alkoksy); og R2 og R3 uavhengig av hverandre er hydrogen eller Cj.g-alkyl, eller som et farmasøytisk akseptabelt salt derav, i kombinasjon med en farmasøytisk aksep- tabel bærer til fremstilling av et far- masøytisk preparat for behandling eller profylakse av menopausesymptomer.The present invention provides new uses of compounds of the general formula (I) wherein R 1, R 4 and R 5 are independently hydrogen, hydroxy, halogen, trifluoromethyl, C 1-6 alkyl, C 1-6 alkoxy or (tertiary amino HCl alkoxy); and R 2 and R 3 are independently hydrogen or C 1-6 alkyl, or as a pharmaceutically acceptable salt thereof, in combination with a pharmaceutically acceptable carrier for the preparation of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms.

NO983178A 1996-01-11 1998-07-10 Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms NO983178L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US983496P 1996-01-11 1996-01-11
US67826196A 1996-07-11 1996-07-11
PCT/DK1997/000008 WO1997025035A1 (en) 1996-01-11 1997-01-09 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms

Publications (1)

Publication Number Publication Date
NO983178L true NO983178L (en) 1998-07-10

Family

ID=26679921

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983178A NO983178L (en) 1996-01-11 1998-07-10 Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms

Country Status (12)

Country Link
EP (1) EP0873120A1 (en)
JP (1) JP2000506505A (en)
KR (1) KR19990077156A (en)
AU (1) AU1367297A (en)
BR (1) BR9706967A (en)
CA (1) CA2241623A1 (en)
CZ (1) CZ217298A3 (en)
HU (1) HUP9902683A3 (en)
IL (1) IL124882A0 (en)
NO (1) NO983178L (en)
PL (1) PL327831A1 (en)
WO (1) WO1997025035A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
ES2238034T3 (en) * 1999-12-30 2005-08-16 Signal Pharmaceuticals Llc COMPOUNDS AND METHODS FOR THE MODULATION OF ESTROGEN RECEPTORS.
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
AU2005287865B2 (en) 2004-09-21 2012-02-16 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
CN102406650A (en) 2004-10-20 2012-04-11 恩多研究公司 Sex steroid precursors alone or in combination with selective estrogen receptor modulator for prevention and treatment of vaginal dryness and sexual dysfunction in postmenop
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
CN102940619A (en) 2007-10-16 2013-02-27 利普生物药剂公司 Trans-clomiphene for metabolic syndrome
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
KR20140089402A (en) 2010-06-16 2014-07-14 앙도르쉐르슈 인코포레이티드 Methods of treating or preventing estrogen-related diseases
WO2012061413A2 (en) 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compositions and methods for the treatment of cancer
MX2014009322A (en) 2012-02-29 2014-11-10 Repros Therapeutics Inc Combination therapy for treating androgen deficiency.
BR112016018099B8 (en) 2014-02-07 2023-01-17 Novogen ltd FUNCTIONALIZED BENZOPYRAN COMPOUNDS AND THEIR USE
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
AU2016215515B2 (en) 2015-02-02 2020-04-30 Mei Pharma, Inc. Combination therapies
JP7048505B2 (en) 2015-11-10 2022-04-05 パラクリン セラピューティクス エービー Treatment of ER-negative breast cancer with PDGF-CC inhibitors and antiestrogens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency

Also Published As

Publication number Publication date
AU1367297A (en) 1997-08-01
CA2241623A1 (en) 1997-07-17
IL124882A0 (en) 1999-01-26
KR19990077156A (en) 1999-10-25
CZ217298A3 (en) 1999-01-13
WO1997025035A1 (en) 1997-07-17
EP0873120A1 (en) 1998-10-28
BR9706967A (en) 1999-05-04
JP2000506505A (en) 2000-05-30
HUP9902683A2 (en) 2001-04-28
HUP9902683A3 (en) 2001-08-28
PL327831A1 (en) 1999-01-04

Similar Documents

Publication Publication Date Title
NO983178L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
NO20025821L (en) 2-aminocarbonyl-9H-purine
NO20044501L (en) [1,4] diazenino [6,7,1-IJ] quinoline derivatives such as antipsychotics and antidepressants
TR200201874T2 (en) New compounds and compositions as protease inhibitors.
MX9702865A (en) 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-idoles as estrogenic agents.
HUP0101999A2 (en) 4-hydroxyquinoline-3-carboxamides and hydrazides use of them and pharmaceutical compositions containing them
SE0104332D0 (en) Therapeutic agents
AP9701041A0 (en) Pyridylpyrrole compounds.
NO996108L (en) 9 oksinerytromycinderivater
ATE300541T1 (en) PYRAZOLOPYRIDINE DERIVATIVES
NO971625L (en) Novel peptides with immunomodulatory effects
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
NZ528997A (en) Sulfonamides
NO20050664L (en) 2.4 substituted indoles and their use as 5-HT6 modulators
NO20050666L (en) 2,7-substituted indoles and their use as 5-HT6 modulators
NO984740L (en) Isatin derivatives such as acetylcholinesterase inhibitors and analgesics
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
NO991230L (en) Tricyclic compounds for inhibition of G protein function and for the treatment of proliferative diseases
NO975681L (en) Benzisoxazole and indazole derivatives as antipsychotic agents
NO20014855L (en) N- (2-phenyl-4-aminobutyl) -1-naphthamides as neurokinin-1 receptor antagonists
NO973340L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of obesity
NO973342L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative diseases
NO973241L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinemia, hypertriglyceridemia, hyperlipidemia or hypercholesterolemia, or arteriosclerosis, or for anticoagulant b.
NO973242L (en) Use of 3,4-diphenylchromanes for the preparation of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiological gynecomastia
NO983444L (en) Benzo (c) quinolizine derivatives, their preparation and use as 5 <alfa> reductase inhibitors